FDA adds warnings to Forest Labs' Celexa label
(Reuters) - Health regulators added new warnings to the label of Forest Laboratories Inc's antidepressant Celexa and its generic versions about a potential risk of rare heart diseases.
The changed drug label has a particular caution for patients with certain conditions because of the risk of QT syndrome -- a disorder of the heart's electrical activity.
The FDA also said the maximum recommended dose of Celexa, or citalopram, is 20 mg per day for patients older than 60 years.
(Reporting by Kavyanjali Kaushik in Bangalore; Editing by Don Sebastian)
- Police hunt for motive as search for Malaysian jet spans hemispheres |
- Russia media say Crimea votes 93 percent to quit Ukraine |
- Ukraine, Russia agree Crimea truce until March 21-Ukraine minister
- Malaysian PM says lost airliner was diverted deliberately |
- Democrats seek ways to limit Obamacare fallout after Florida defeat